233 related articles for article (PubMed ID: 30652072)
41. Diagnostic and prognostic value of
Wang MQ; Yin QY; Chen YR; Zhu SL
Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
[TBL] [Abstract][Full Text] [Related]
42. Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Lv X; Zhao Y; Zhang L; Zhou S; Zhang B; Zhang Q; Jiang L; Li X; Wu H; Zhao L; Wei M; He M
J Cell Biochem; 2020 Feb; 121(2):1842-1854. PubMed ID: 31633246
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
44. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
45. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
[TBL] [Abstract][Full Text] [Related]
46. Hypomethylated gene NRP1 is co-expressed with PDGFRB and associated with poor overall survival in gastric cancer patients.
Wang G; Shi B; Fu Y; Zhao S; Qu K; Guo Q; Li K; She J
Biomed Pharmacother; 2019 Mar; 111():1334-1341. PubMed ID: 30841447
[TBL] [Abstract][Full Text] [Related]
47. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
[TBL] [Abstract][Full Text] [Related]
48. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
[TBL] [Abstract][Full Text] [Related]
49. A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
Li Y; Li R; Wang X; Yuan Y; Zhang Y
Biomed Res Int; 2021; 2021():6633289. PubMed ID: 33969120
[TBL] [Abstract][Full Text] [Related]
50. High FAM189B Expression and Its Prognostic Value in Patients with Gastric Cancer.
Wu CL; Tan QX; Liu D; Jiang JE; Lu T; Huang ZM; Su YJ
Biomed Res Int; 2021; 2021():8875971. PubMed ID: 34124264
[TBL] [Abstract][Full Text] [Related]
51. Identification of
Liu Y; Liao XW; Qin YZ; Mo XW; Luo SS
Biomed Res Int; 2020; 2020():9280841. PubMed ID: 32190689
[TBL] [Abstract][Full Text] [Related]
52. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
53. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
54. Circular RNAs as diagnostic biomarkers in gastric cancer: A meta-analysis review.
Jiang F; Hong F; Shah MW; Shen X
Pathol Res Pract; 2019 Jun; 215(6):152419. PubMed ID: 31043351
[TBL] [Abstract][Full Text] [Related]
55. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
56. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
57. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
58. Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
Yue C; Ren Y; Ge H; Yan L; Xu Y; Wang G; Wu J
J Cell Physiol; 2019 Dec; 234(12):23685-23694. PubMed ID: 31169303
[TBL] [Abstract][Full Text] [Related]
59. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
60. Association between MIC-1 and Type 2 Diabetes: A Combined Analysis.
Lu J; Zhang Y; Dong X; Lu J; Zhang C; Liu J; Yu Q; Teng H; Yao Q; Yin J; Qin L
Dis Markers; 2019; 2019():7284691. PubMed ID: 31827641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]